abstract |
The present invention relates to a novel opioid modulator effective in reducing pharmacologically induced weight gain due to the use of atypical antipsychotics. The present invention provides methods for reducing atipsychotic-induced weight gain in a patient, suppressing food intake induced by atypical antipsychotic drugs, and reducing ghrelin levels. |